Here are five things to know:
1. Initially, the two will focus on developing products that accelerate and improve individualized treatment options for cancer and critical care patients.
2. Roche and GE hope to develop a digital platform that uses advanced analytics to provide workflow solutions as well as apps to support clinical decisions.
3. The new solutions will enable integration of in-vivo and in-vitro data, patient records, medical best practices, real-time monitoring and research outcomes. Clinicians will also have decision support to provide correct treatment and quality care to patients.
4. GE is a leader in medical imaging equipment, and Roche is global leader in in-vitro diagnostics.
5. “This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree,” said Kieran Murphy, GE Healthcare CEO and president. “We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients
and the healthcare industry.”
More articles on imaging:
Prince William scrubs in to observe surgery using da Vinci Surgical System: 4 takeaways
China performs 1st robotic surgery: 5 things to know
The da Vinci Surgical System Xi arrives at Gulf Coast Regional Medical Center: 4 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
